DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Miller K, OʼNeill AM, Dang CT et al.
Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103.
J Clin Oncol 2014;
32 (Suppl. 05) (Suppl.; Abstr. 500)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.